Histological diagnosis of sALCL (ALK positive and ALK negative);
Have received BV-CHP as front-line therapy in real life setting;
Availability of histological material of initial ALCLs diagnosis: a FFPE block from an excisional/incisional biopsy must be provided for patient enrollment. FNAB and GNAB will not be considered for the study;
Signed written informed consent
You may not be if
Histological diagnosis other than sALCL;
Front line treatment other than BV-CHP;
Patients treated with BV-CHP in the contest of a clinical trial;
Refuse to sign a written informed consent.
Clareo Health | BV-CHP Real-life and Biological Evidences in Patients With sALCL
